Ledaga product information

Introduction

This is a summary of the European Public Assessment Report (EPAR) for Ledaga. It explains how the Agency assessed the drug to recommend its authorisation in the EU and its conditions of use. It is not intended as practical advice on the use of Ledaga.

View product information

Don't miss our upcoming events